Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia

    July 2023 in “ Obstetrics & Gynecology ”
    Yoshihide Inayama, Shiro Takamatsu, Junzo Hamanishi … Masaki Mandai
    Studysummary In this study, imiquimod was found to increase regression of cervical intraepithelial neoplasia compared to placebo, though it commonly caused side effects that rarely led to treatment discontinuation.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Imiquimod-Induced Effluvium After Intravaginal Application for Treatment of Cervical Intraepithelial Neoplasia JAAD Case Reports · 2019